Literature DB >> 30612493

High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings From the PAMELA Population.

Cesare Cuspidi1,2, Rita Facchetti1, Michele Bombelli1, Marijana Tadic3, Carla Sala4, Guido Grassi1, Giuseppe Mancia1.   

Abstract

Cross-sectional and longitudinal data analysis of the PAMELA (Pressioni Monitorate E Loro Associazioni) population was performed to assess the association between prehypertension and left ventricular hypertrophy (LVH) at entry and the risk of new-onset LVH associated to this condition in the subset of participants with normal LV mass index (LVMI). A total of untreated 1397 participants with measurable echocardiographic parameters at baseline were considered in the cross-sectional analysis. The longitudinal analysis included 880 participants without LVH at baseline and with measurable LVMI at follow-up examination performed 10 years later. At entry, after adjustment for major confounders LVH prevalence rates (LVM/body surface area) showed a significant, progressive increase from the normotensive (2.1%), to prehypertension (6.7%), and hypertension group (18.3%). The incidence of LVH increased progressively from the normotensive to prehypertension and hypertension group (9.0%, 23.2%, and 36.5%, respectively). The risk of new LVH was significantly greater in prehypertension who progressed to sustained hypertension (odds ratio, 4.21; CI, 1.64-10.83; P=0.003) than in those with persistent prehypertension (odds ratio, 1.89; CI, 0.77-5.11; P=0.21) compared with persistent normotensive participants after adjustment for age, sex, baseline LVMI, obesity, glucose, creatinine, total cholesterol and the use of antihypertensive drugs at follow-up. Further adjustments for changes in body mass index, metabolic variables, and creatinine during the follow-up did not modify the strength of association between prehypertension and new-onset LVH. Our findings offer a new piece of evidence on the association of prehypertension with LVH and support the view that preventive actions for this condition affecting a large fraction of the general population should be intensified.

Entities:  

Keywords:  body mass index; echocardiography; hypertrophy; population; prehypertension

Mesh:

Year:  2019        PMID: 30612493     DOI: 10.1161/HYPERTENSIONAHA.118.12114

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

Review 1.  Pharmacotherapy for hypertension-induced left ventricular hypertrophy.

Authors:  Leire Leache; Marta Gutiérrez-Valencia; Rosa M Finizola; Elizabeth Infante; Bartolome Finizola; Jordi Pardo Pardo; Yris Flores; Ricardo Granero; Kaduo J Arai
Journal:  Cochrane Database Syst Rev       Date:  2021-10-10

2.  Cardiovascular Hypertension-Mediated Organ Damage in Hypertensive Urgencies and Hypertensive Outpatients.

Authors:  Fabrizio Vallelonga; Marco Cesareo; Leonardo Menon; Lorenzo Airale; Dario Leone; Anna Astarita; Giulia Mingrone; Maria Tizzani; Enrico Lupia; Franco Veglio; Alberto Milan
Journal:  Front Cardiovasc Med       Date:  2022-05-16

3.  Association of Office and Ambulatory Blood Pressure with Left Ventricular Structure and Function in Hypertensive Patients.

Authors:  Zhuo Sang; Xianli Zeng; Xiaohui Yuan; Xiaolin Wang; Liancong Fu; Wenwen Zhuang
Journal:  Int J Gen Med       Date:  2022-05-04

4.  Association of ambulatory blood pressure with coronary microvascular and cardiac dysfunction in asymptomatic type 2 diabetes.

Authors:  Jian L Yeo; Gaurav S Gulsin; Emer M Brady; Abhishek Dattani; Joanna M Bilak; Anna-Marie Marsh; Manjit Sian; Lavanya Athithan; Kelly S Parke; Joanne Wormleighton; Matthew P M Graham-Brown; Anvesha Singh; J Ranjit Arnold; Claire Lawson; Melanie J Davies; Hui Xue; Peter Kellman; Gerry P McCann
Journal:  Cardiovasc Diabetol       Date:  2022-05-28       Impact factor: 8.949

Review 5.  The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions.

Authors:  Amedeo Tirandi; Federico Carbone; Fabrizio Montecucco; Luca Liberale
Journal:  Eur J Clin Invest       Date:  2021-11-08       Impact factor: 5.722

6.  Patients with Dipper and Nondipper High-Normal Blood Pressure Were Associated with Left Ventricular Mass.

Authors:  Fan-Kai Xiao; Ping Li; Zhan-Ying Han; Li Jing; Shaohua Hua; Luo-Sha Zhao
Journal:  Int J Hypertens       Date:  2021-12-21       Impact factor: 2.420

7.  Prevalence, Predictors, Progression, and Prognosis of Hypertension Subtypes in the Framingham Heart Study.

Authors:  Maximillian T Bourdillon; Rebecca J Song; Ibrahim Musa Yola; Vanessa Xanthakis; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2022-03-09       Impact factor: 6.106

8.  Blood Pressure Trajectories for 16 Years and the Development of Left Ventricular Hypertrophy and Increased Left Atrial Size: The Korean Genome and Epidemiology Study.

Authors:  Seong Hwan Kim; Ju-Mi Lee; Seung Ku Lee; Chol Shin; Jae-Hyeong Park
Journal:  Int J Hypertens       Date:  2022-07-18       Impact factor: 2.434

9.  Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats.

Authors:  Jie Li; Krzysztof Minćzuk; James C Massey; Nancy L Howell; R Jack Roy; Soumen Paul; James T Patrie; Christopher M Kramer; Frederick H Epstein; Robert M Carey; Heinrich Taegtmeyer; Susanna R Keller; Bijoy K Kundu
Journal:  J Am Heart Assoc       Date:  2020-04-04       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.